Acurx Pharmaceuticals Highlights New Data on Ibeza...
Category : Clinical Trial Update 30 October 2025Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP), a late-stage biopharmaceutical company developing a new...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP), a late-stage biopharmaceutical company developing a new...
Jenscare Scientific Co., Ltd. (HKEX: 9877) presented new clinical data for three of its proprietary...
Ascletis Pharma Inc. (HKEX: 1672) has announced the selection of ASC36, a once-monthly subcutaneous...
Johnson & Johnson (J&J) has announced new 96-week data from the long-term extensions (LTE) o...
Jupiter Endovascular, Inc., a medical technology company developing next-generation endovascular int...